The Holden Comprehensive Cancer Center and the Department of Pharmaceutical Sciences and Experimental Therapeutics present:
Dr. Arthur Krieg
CEO of Checkmate Pharmaceuticals
“The Role of CpG Oligonucleotides in Immuno-oncology: From Bench to Bedside to Pharma to Bedside”
Individuals with disabilities are encouraged to attend all University of Iowa–sponsored events. If you are a person with a disability who requires a reasonable accommodation in order to participate in this program, please contact in advance at or .